KBC Group CEO, Johan Thijs, announces 'KBC 2013 and beyond'
During a press and analyst conference in Brussels today, Johan Thijs, CEO of the KBC group since May 2012, presented the…
During a press and analyst conference in Brussels today, Johan Thijs, CEO of the KBC group since May 2012, presented the…
SuppreMol GmbH, a privately held biopharmaceutical company developing novel therapeutics for the treatment of autoimmune…
Arpida Ltd. (SWX: ARPN) today announced that Dr Jürgen Raths will succeed Dr Khalid Islam as Chief Executive Officer. Dr…
. - More than 250 participants attend the Swiss Equity biotech day 2010 where executives from seven publicly-traded and…
In just a short time, BMW Welt has become one of the most popular tourist attractions in Munich. Around five million peo…